Recent advances in understanding and managing T-cell lymphoma

Owing to the rarity of peripheral T-cell lymphoma (PTCL) and the heterogeneity of subtypes, there are no compelling data to guide the therapeutic approaches for such patients. Over the years, there have been remarkable advances in molecular subtyping and treatment of PTCL, although there are still m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jun Ho, Kim, Seok Jin, Kim, Won Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728196/
https://www.ncbi.nlm.nih.gov/pubmed/29259783
http://dx.doi.org/10.12688/f1000research.12573.1
_version_ 1783286010242662400
author Yi, Jun Ho
Kim, Seok Jin
Kim, Won Seog
author_facet Yi, Jun Ho
Kim, Seok Jin
Kim, Won Seog
author_sort Yi, Jun Ho
collection PubMed
description Owing to the rarity of peripheral T-cell lymphoma (PTCL) and the heterogeneity of subtypes, there are no compelling data to guide the therapeutic approaches for such patients. Over the years, there have been remarkable advances in molecular subtyping and treatment of PTCL, although there are still many areas to be explored. In this review, we summarize recent updates on the evolution of understanding and treatment for PTCL.
format Online
Article
Text
id pubmed-5728196
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-57281962017-12-18 Recent advances in understanding and managing T-cell lymphoma Yi, Jun Ho Kim, Seok Jin Kim, Won Seog F1000Res Review Owing to the rarity of peripheral T-cell lymphoma (PTCL) and the heterogeneity of subtypes, there are no compelling data to guide the therapeutic approaches for such patients. Over the years, there have been remarkable advances in molecular subtyping and treatment of PTCL, although there are still many areas to be explored. In this review, we summarize recent updates on the evolution of understanding and treatment for PTCL. F1000 Research Limited 2017-12-12 /pmc/articles/PMC5728196/ /pubmed/29259783 http://dx.doi.org/10.12688/f1000research.12573.1 Text en Copyright: © 2017 Yi JH et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Yi, Jun Ho
Kim, Seok Jin
Kim, Won Seog
Recent advances in understanding and managing T-cell lymphoma
title Recent advances in understanding and managing T-cell lymphoma
title_full Recent advances in understanding and managing T-cell lymphoma
title_fullStr Recent advances in understanding and managing T-cell lymphoma
title_full_unstemmed Recent advances in understanding and managing T-cell lymphoma
title_short Recent advances in understanding and managing T-cell lymphoma
title_sort recent advances in understanding and managing t-cell lymphoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728196/
https://www.ncbi.nlm.nih.gov/pubmed/29259783
http://dx.doi.org/10.12688/f1000research.12573.1
work_keys_str_mv AT yijunho recentadvancesinunderstandingandmanagingtcelllymphoma
AT kimseokjin recentadvancesinunderstandingandmanagingtcelllymphoma
AT kimwonseog recentadvancesinunderstandingandmanagingtcelllymphoma

Ejemplares similares